BCL2 molecular target information overview


  • Molecular name:BCL2, BCL2 apoptosis regulator
  • Gene family:Protein phosphatase 1 regulatory subunits; BCL2 family
  • Alias:Bcl-2; PPP1R50
  • Alias:protein phosphatase 1, regulatory subunit 50; B-cell CLL/lymphoma 2; BCL2, apoptosis regulator

  • BCL2 molecular target review


    B-cell lymphoma 2 (Bcl-2), a founding member of the Bcl-2 family of regulatory proteins, regulates apoptosis by either inducing apoptosis (pro-apoptotic) or inhibiting apoptosis (anti-apoptotic). Bcl-2 has been identified as an important anti-apoptotic protein and is therefore classified as an oncogene. Bcl-2 regulates mitochondrial dynamics and is involved in the regulation of mitochondrial fusion and fission. In addition, in pancreatic beta cells, Bcl-2 and Bcl-XL are involved in controlling metabolic activity and insulin secretion. Damage to the Bcl-2 gene can cause many cancers, including melanoma, breast cancer, prostate cancer, chronic lymphocytic leukemia, and lung cancer, and may also be associated with schizophrenia and autoimmune diseases. Bcl-2 is also a cause of resistance to cancer treatment.


    Human BCL2 Molecular Target Information


    Molecular name: BCL2, BCL2 apoptosis regulator


    Alias:

    • apoptosis regulator Bcl-2
    • B-cell CLL/lymphoma 2
    • b-cell leukemia/lymphoma 2
    • Bcl-2
    • Bcl-2a
    • Bcl-2?
    • BCL2, apoptosis regulator
    • PPP1R50
    • protein phosphatase 1, regulatory subunit 50

    Gene sequence:NCBI_Gene: 596

    Protein sequence: UniProtKB: P10415


    Human BCL2 target molecular function (prediction)


    Acts upstream of or within several processes, including B cell proliferation; apoptotic signaling pathway; and negative regulation of apoptotic process. Located in endoplasmic reticulum; mitochondrial outer membrane; and nucleus. Part of pore complex. Implicated in several diseases, including carcinoma (multiple); hematologic cancer (multiple); intracranial aneurysm; prostate cancer; and urinary bladder cancer.


    Mouse Bcl2 molecular target information


    Molecular Name: Bcl2, B cell leukemia/lymphoma 2


    Alias:

    • AW986256
    • Bcl-2
    • C430015F12Rik
    • D630044D05Rik
    • D830018M01Rik
    • expressed sequence AW986256
    • RIKEN cDNA C430015F12 gene
    • RIKEN cDNA D630044D05 gene
    • RIKEN cDNA D830018M01 gene


    Gene sequence:NCBI_Gene: 12043

    Protein sequence:


    Mouse Bcl2 target molecular function (prediction)


    Acts upstream of or within several processes, including animal organ development; apoptotic signaling pathway; and negative regulation of programmed cell death. Located in several cellular components, including mitochondrial membrane; myelin sheath; and nuclear membrane. Is expressed in several structures, including central nervous system; genitourinary system; gut; limb; and sensory organ. Used to study oligomeganephronia. Human ortholog(s) of this gene implicated in several diseases, including Alzheimer's disease; carcinoma (multiple); hematologic cancer (multiple); intracranial aneurysm; and prostate cancer. Orthologous to human BCL2 (BCL2 apoptosis regulator).


    Rat Bcl2 molecular target information


    Molecular name: Bcl2, BCL2, apoptosis regulator

    Alias:

    • apoptosis regulator Bcl-2
    • B cell lymphoma 2 associated oncogene
    • B-cell CLL/lymphoma 2
    • B-cell leukemia/lymphoma 2
    • Bcl-2
    • Bcl-2alpha
    • Bcl2-like protein

    Gene sequence:NCBI_Gene: 24224

    Protein sequence:


    Rat Bcl2 target molecule function (prediction)


    Enables BH domain binding activity. Involved in several processes, including response to peptide; response to purine-containing compound; and response to vitamin. Located in cytosol; mitochondrial crista; and perinuclear region of cytoplasm. Used to study several diseases, including brain ischemia (multiple); end stage renal disease; gastric ulcer; intestinal disease (multiple); and neurodegenerative disease (multiple). Human ortholog(s) of this gene implicated in several diseases, including carcinoma (multiple); hematologic cancer (multiple); intracranial aneurysm; prostate cancer; and urinary bladder cancer. Orthologous to human BCL2 (BCL2 apoptosis regulator).